NSE ScannerFMCG & Food · Household/Personal Care · NSE: MEDISTEP · data 2026-10-31
Medistep Healthcare Limited
In plain words
Price: 35.0% below its 52-week high of ₹30.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹71 cr |
| Net profit (last 12 months) | ₹6 cr |
| Sales growth, 3 years (yearly) | 36.8% |
| Profit growth, 3 years (yearly) | 86.6% |
At a glance
P/E 4.6, P/B 0.7, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 21.7%, ROCE 29.8%, operating margin 11.6%: how much profit it earns on the money it uses.
Debt/equity 0.14, Profit growth 86.6% and sales growth 36.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (21.7%).
- Profit grew 86.6% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Medistep Healthcare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.14.
What is Medistep Healthcare Limited's P/E ratio?
About 4.6, based on the last 12 months' earnings and a price of ₹19.5 (data 2026-10-31).
What is the 52-week high and low of Medistep Healthcare Limited?
The 52-week high is ₹30 and the 52-week low is ₹16.5.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Medistep Healthcare Limited | ₹19.5 | ₹28 cr | 4.6 | 0.7 | 21.7% | 29.8% | 0.14 | -25.9% |
| Bajaj Consumer Care Limited | ₹370.15 | ₹4,853 cr | 19.3 | 5.4 | 25.3% | 26.1% | 0.02 | +37.1% |
| Sacheerome Limited | ₹412 | ₹922 cr | 32.4 | 6.2 | 27% | 32.1% | 0 | +81.5% |
| Kaya Limited | ₹289.95 | ₹439 cr | — | — | — | -53.9% | — | -34.0% |
| Dhariwalcorp Limited | ₹24.5 | ₹115 cr | 19.2 | 3.8 | 17.9% | 13.5% | 0.12 | -87.1% |
| JHS Svendgaard Laboratories Limited | ₹7.99 | ₹70 cr | — | — | -1.1% | -2.3% | 0.09 | -37.9% |
Compare MEDISTEP with BAJAJCON in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MEDISTEP in NSE Scanner →